VAERS Explorer
Back to explore

Report #2897634

Received May 22, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
Recovered
Recovered
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNK

Symptoms (1)

Syncope

Symptom narrative

Nurse reported that there have been 3 boys and 1 girl who have fainted in their office after being administered GARDASIL9; This Spontaneous report was received from a Nurse via Company Representative referred to a Male patient of unknown age. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9), (Strength, dose, dose number, vaccination scheme, anatomical route of vaccination, lot number., and expiration date were not reported), as prophylaxis. On an unknown date, the patient had fainted in the office after being administered human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9) (Syncope). On an unknown date, the patient recovered from Syncope. The reporter did not assess the causal relationship between the syncope and human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9). Lot # is being requested and will be submitted if received. Upon internal review, the event Syncope was determined to be Medically Significant. This is one of 4 reports from the same reporter.